Member LoginDividend CushionValue Trap |
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for
any changes.
Jun 20, 2013
Generic Pharmaceuticals: Patent Expiration and Low Global Utilization Rates Create Opportunities
Big Pharma is not dead, but neither are the generics. Let’s take a look at opportunities presented from patent expiry in the US and low generic utilization rates across the globe. We don’t think investors are expecting the “mountain” of opportunities in 2015. Jun 20, 2013
FedEx Leaps Over a Low Bar
Shipping giant FedEx set expectations low, helping fourth quarter results easily exceed expectations. Jun 19, 2013
Mortgage REITs Are Still Hurting
A rising 10-year Treasury yield and American Capital’s dividend cut have put downward pressure on the mREIT industry. Jun 19, 2013
Pool Corp Remains Overvalued Despite Fall
Pool Corp’s shares are falling in response to a reduced outlook. We think shares still look expensive. Jun 19, 2013
Growth in Asia Should Drive Ford to New Highs
Ford CEO Alan Mulally suggests Asia-Pacific could account for 40% of sales in the future. Let’s take a look at what this means. Jun 18, 2013
Hormel’s Guidance Cut Isn’t Drastic
Shares of Hormel fell after management cut guidance. We aren’t worried about the company, but we think shares now look fairly valued. Jun 18, 2013
Tesla: Can a Savvy Start-up Become the Next Great American Auto Company?
We take a deep dive into one of the most innovative companies in our coverage universe. Jun 14, 2013
Asset Divestitures Progress at Best Ideas Portfolio Holding Rio Tinto
Rio Tinto sells its Eagle project for $325 million. Jun 13, 2013
Does ShopHouse Justify Chipotle’s Valuation?
We don’t think so. Let’s take a look at the concept, and how it could play out. Jun 12, 2013
Lululemon’s CEO Departure: Sell-off Justified?
Lululemon’s slowing sales growth and its CEO’s departure has scared off some growth investors.
prev12345678910111213141516171819202122232425
26272829303132333435363738394041424344454647484950 51525354555657585960616263646566676869707172737475 767778798081828384858687888990919293949596979899100 101102103104105106107108109110111112113114115116117118119120 121122123124125126127128129130131132133134135136137138139140 141142143144145146147148149150151152153154155156157158159160 161162163164165166167168169170171172173174175176177178179180 181182183184185186187188189190191192193194195196197198199200 201202203204205206207208209210211212213214215216217218219220 221222223224225226227228229230231232233234235236237238239240 241242243244245246247248249250251252253254255256257258259260 261262263264265266267268269270271272273274275276277278279280 281282283284285286287288289290291292293294295296297298299300 301302303304305306307308309310311312313314315316317318319320 321322323324325326327328329330331332333334335336337338339340 341342343344345346347348349350351352353next The High Yield Dividend Newsletter, Best Ideas
Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on
this website are for information purposes only and should not be considered a solicitation to buy or sell any
security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s
accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or
omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts
no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a
registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees,
and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.
|